NEWS & PRESS

Nucleix Receives CAP Accreditation and CLIA Certification for its San Diego Clinical Laboratory

19/10/2022
SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced...

Nucleix Expands EU Label Indication of Bladder EpiCheck® to Include the Detection of Primary Bladder Cancer and Detection of Primary and Recurrent Upper Tract Urinary Cancer

22/06/2022
SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced...

Bladder cancer monitoring can be done via urine test: "More pleasant for the patient and saves time. It also saves hospitals one million euros per year".

21/06/2022
Bladder cancer monitoring can be done via urine test: "More pleasant for the patient and saves time" "Patients who have had...

The Radboudumc, Nijmegen & Bladder EpiCheck®, won the Silver Award in the "Together in the Lead" Awards from Healthcare Insurer VGZ in the Netherlands.

21/06/2022
We are proud to share that the Radboudumc, Nijmegen & Bladder EpiCheck®, won the Silver Award in the "Together in...

Bladder EpiCheck® Included in 2022 European Association of Urology (EAU) Clinical Guidelines on Non-Muscle Invasive Bladder Cancer (NMIBC) Clinical Guidelines Support Adoption of Urinary Biomarker Tests with High Sensitivity and Negative Predictive Values for High-Grade Disease to Replace and/or Postpone Cystoscopies in Low- and Intermediate-Risk NMIBC Publication of Meta-Analysis in European Urology Oncology Showed Bladder EpiCheck has Best Performance Amongst Guideline-Recommended Urinary Biomarker Tests

16/03/2022
SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced...

STAY UPDATED ON THE LATEST NEWS FROM NUCLEIX!

SOCIAL MEDIA

Subscribe to one of our social media channels

close

Subscription Confirmation Required

Go to your email inbox

Go to your email inbox

Go to the inbox of the email
address you just used to sign up.

Open the confirmation email

Open the confirmation email

Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “info@nucleix.com”.

Click the confirmation link

Click the confirmation link

Click on the link inside the
email and you’re good to go.

GOT IT !